Found: 32
Select item for more details and to access through your institution.
MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2558, doi. 10.1111/all.16212
- By:
- Publication type:
- Article
In chronic spontaneous urticaria, increased Galectin‐9 expression on basophils and eosinophils is linked to high disease activity, endotype‐specific markers, and response to omalizumab treatment.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2435, doi. 10.1111/all.16239
- By:
- Publication type:
- Article
Mast cell responses in a mouse model of food allergy are regulated via a ST2/IL‐4 axis.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2561, doi. 10.1111/all.16257
- By:
- Publication type:
- Article
Recent patents in allergy and immunology: The interleukin‐2 receptor pathway agonist rezpegaldesleukin (REZPEG) for the rescue of regulatory T cells in chronic inflammatory and autoimmune diseases.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2565, doi. 10.1111/all.16271
- By:
- Publication type:
- Article
Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2448, doi. 10.1111/all.16256
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2313, doi. 10.1111/all.16287
- Publication type:
- Article
Elucidating allergic reaction mechanisms in response to SARS‐CoV‐2 mRNA vaccination in adults.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2502, doi. 10.1111/all.16231
- By:
- Publication type:
- Article
Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2366, doi. 10.1111/all.16183
- By:
- Publication type:
- Article
An algorithm for the diagnosis and treatment of chronic inducible urticaria, 2024 update.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2573, doi. 10.1111/all.16250
- By:
- Publication type:
- Article
Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2319, doi. 10.1111/all.16246
- By:
- Publication type:
- Article
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2470, doi. 10.1111/all.16132
- By:
- Publication type:
- Article
Disease modification in chronic spontaneous urticaria.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2396, doi. 10.1111/all.16243
- By:
- Publication type:
- Article
Pyroptosis, gasdermins and allergic diseases.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2380, doi. 10.1111/all.16236
- By:
- Publication type:
- Article
An algorithm for the management of radiocontrast media hypersensitivity, 2024 update.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2570, doi. 10.1111/all.16191
- By:
- Publication type:
- Article
Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2551, doi. 10.1111/all.16190
- By:
- Publication type:
- Article
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2482, doi. 10.1111/all.16210
- By:
- Publication type:
- Article
Lipopolysaccharides in combination with amoxicillin increases basophil activation test sensitivity to amoxicillin IgE‐mediated hypersensitivity.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2537, doi. 10.1111/all.16133
- By:
- Publication type:
- Article
Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2554, doi. 10.1111/all.16194
- By:
- Publication type:
- Article
Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2547, doi. 10.1111/all.16175
- By:
- Publication type:
- Article
Prior respiratory syncytial viral infection contributes to severe COVID‐19 illness: A nationwide cohort study.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2534, doi. 10.1111/all.16118
- By:
- Publication type:
- Article
Mouse IgE clone SPE‐7 can contain functional mouse IgG.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2544, doi. 10.1111/all.16141
- By:
- Publication type:
- Article
CD8+ T‐cell efficiency is affected by the form of membrane lipids in lipid rafts.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2577, doi. 10.1111/all.16176
- By:
- Publication type:
- Article
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2346, doi. 10.1111/all.16151
- By:
- Publication type:
- Article
Lin<sup>−</sup>CD117<sup>+</sup>CD34<sup>+</sup>FcεRI<sup>+</sup> progenitor cells are increased in chronic spontaneous urticaria and predict clinical responsiveness to anti‐IgE therapy.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2423, doi. 10.1111/all.16127
- By:
- Publication type:
- Article
An algorithm for the diagnosis, pathogenesis and treatment of chronic spontaneous urticaria, 2024 update.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2567, doi. 10.1111/all.16113
- By:
- Publication type:
- Article
Clinical applicability of AI‐based prognosis prediction for a rare ocular surface disease.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2542, doi. 10.1111/all.16136
- By:
- Publication type:
- Article
Mast cell activation identified through urine mediators.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2531, doi. 10.1111/all.16109
- By:
- Publication type:
- Article
Blood basophils and asthma among participants from CONSTANCES, the French population‐based cohort.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2527, doi. 10.1111/all.16093
- By:
- Publication type:
- Article
Mast cell chymase suppresses functional parameters in primary human airway smooth muscle cells.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2524, doi. 10.1111/all.16085
- By:
- Publication type:
- Article
High burden of clonal mast cell disorders and hereditary α‐tryptasemia in patients who need Hymenoptera venom immunotherapy.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2458, doi. 10.1111/all.16084
- By:
- Publication type:
- Article
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2414, doi. 10.1111/all.16082
- By:
- Publication type:
- Article
Reply to Correspondence to "Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—factor analysis".
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2580, doi. 10.1111/all.16074
- By:
- Publication type:
- Article